Fmcna - Benton is a medicare approved dialysis facility center in Benton, Arkansas and it has 16 dialysis stations. It is located in Saline county at 2101 Congo Rd, Benton, AR, 72015. You can reach out to the office of Fmcna - Benton at (501) 776-1418. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fmcna - Benton has the following ownership type - Profit. It was first certified by medicare in April, 1999. The medicare id for this facility is 042556 and it accepts patients under medicare ESRD program.
| Name | Fmcna - Benton |
|---|---|
| Location | 2101 Congo Rd, Benton, Arkansas |
| No. of Dialysis Stations | 16 |
| Medicare ID | 042556 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 2101 Congo Rd, Benton, Arkansas, 72015 | |
| (501) 776-1418 | |
News Archive
Deep brain stimulation, increasingly recognized as an effective therapy for certain cases of Parkinson's disease, dystonia and tremor, also may help patients who suffer from obsessive-compulsive disorder or depression that fails to respond to other treatments.
Researchers have capitalized on the unique properties of a sperm cell to follow cell membrane fusion as it occurs during fertilization, tracking the full cascade of events for the first time. The findings could reveal new ways to enhance or block fertilization, as well as how to control the secretion of neurotransmitters and hormones such as insulin.
This week at the annual Congress of Neurological Surgeons (CNS), Medtronic (NYSE: MDT) announced the Conformite Europeen (CE) mark and international launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions.
EnWave Corporation has received positive comments from the Patent Examiner with regard to the Company's Patent Co-Operation Treaty ("PCT") patent application for nutraREVTM equipment concept and use, leading the Company to believe that a favorable International Preliminary Report on Patentability ("IPRP") is forthcoming.
› Verified 5 days ago
| NPI Number | 1720190622 |
| Organization Name | Benton Dialysis |
| Doing Business As | Little Rock Dialysis, Inc. |
| Address | 2101 Congo Benton, Arkansas, 72015 |
| Phone Number | (501) 776-1418 |
News Archive
Deep brain stimulation, increasingly recognized as an effective therapy for certain cases of Parkinson's disease, dystonia and tremor, also may help patients who suffer from obsessive-compulsive disorder or depression that fails to respond to other treatments.
Researchers have capitalized on the unique properties of a sperm cell to follow cell membrane fusion as it occurs during fertilization, tracking the full cascade of events for the first time. The findings could reveal new ways to enhance or block fertilization, as well as how to control the secretion of neurotransmitters and hormones such as insulin.
This week at the annual Congress of Neurological Surgeons (CNS), Medtronic (NYSE: MDT) announced the Conformite Europeen (CE) mark and international launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions.
EnWave Corporation has received positive comments from the Patent Examiner with regard to the Company's Patent Co-Operation Treaty ("PCT") patent application for nutraREVTM equipment concept and use, leading the Company to believe that a favorable International Preliminary Report on Patentability ("IPRP") is forthcoming.
› Verified 5 days ago
| Dialysis patients with Hemoglobin data | 15 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 20 |
News Archive
Deep brain stimulation, increasingly recognized as an effective therapy for certain cases of Parkinson's disease, dystonia and tremor, also may help patients who suffer from obsessive-compulsive disorder or depression that fails to respond to other treatments.
Researchers have capitalized on the unique properties of a sperm cell to follow cell membrane fusion as it occurs during fertilization, tracking the full cascade of events for the first time. The findings could reveal new ways to enhance or block fertilization, as well as how to control the secretion of neurotransmitters and hormones such as insulin.
This week at the annual Congress of Neurological Surgeons (CNS), Medtronic (NYSE: MDT) announced the Conformite Europeen (CE) mark and international launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions.
EnWave Corporation has received positive comments from the Patent Examiner with regard to the Company's Patent Co-Operation Treaty ("PCT") patent application for nutraREVTM equipment concept and use, leading the Company to believe that a favorable International Preliminary Report on Patentability ("IPRP") is forthcoming.
› Verified 5 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 36 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 283 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
News Archive
Deep brain stimulation, increasingly recognized as an effective therapy for certain cases of Parkinson's disease, dystonia and tremor, also may help patients who suffer from obsessive-compulsive disorder or depression that fails to respond to other treatments.
Researchers have capitalized on the unique properties of a sperm cell to follow cell membrane fusion as it occurs during fertilization, tracking the full cascade of events for the first time. The findings could reveal new ways to enhance or block fertilization, as well as how to control the secretion of neurotransmitters and hormones such as insulin.
This week at the annual Congress of Neurological Surgeons (CNS), Medtronic (NYSE: MDT) announced the Conformite Europeen (CE) mark and international launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions.
EnWave Corporation has received positive comments from the Patent Examiner with regard to the Company's Patent Co-Operation Treaty ("PCT") patent application for nutraREVTM equipment concept and use, leading the Company to believe that a favorable International Preliminary Report on Patentability ("IPRP") is forthcoming.
› Verified 5 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Fmcna - Benton with elevated calcium levels.
| Patients with hypercalcemia | 37 |
| Hypercalcemia patient months | 296 |
| Patients with Serumphosphor | 43 |
| Patients with Serumphosphor less than 3.5 mg/dL | 6 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 16 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 25 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 29 |
| Patients with Serumphosphor greater than 7 mg/dL | 25 |
News Archive
Deep brain stimulation, increasingly recognized as an effective therapy for certain cases of Parkinson's disease, dystonia and tremor, also may help patients who suffer from obsessive-compulsive disorder or depression that fails to respond to other treatments.
Researchers have capitalized on the unique properties of a sperm cell to follow cell membrane fusion as it occurs during fertilization, tracking the full cascade of events for the first time. The findings could reveal new ways to enhance or block fertilization, as well as how to control the secretion of neurotransmitters and hormones such as insulin.
This week at the annual Congress of Neurological Surgeons (CNS), Medtronic (NYSE: MDT) announced the Conformite Europeen (CE) mark and international launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions.
EnWave Corporation has received positive comments from the Patent Examiner with regard to the Company's Patent Co-Operation Treaty ("PCT") patent application for nutraREVTM equipment concept and use, leading the Company to believe that a favorable International Preliminary Report on Patentability ("IPRP") is forthcoming.
› Verified 5 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 36 |
| Patient months included in arterial venous fistula and catheter summaries | 237 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 49 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 25 |
News Archive
Deep brain stimulation, increasingly recognized as an effective therapy for certain cases of Parkinson's disease, dystonia and tremor, also may help patients who suffer from obsessive-compulsive disorder or depression that fails to respond to other treatments.
Researchers have capitalized on the unique properties of a sperm cell to follow cell membrane fusion as it occurs during fertilization, tracking the full cascade of events for the first time. The findings could reveal new ways to enhance or block fertilization, as well as how to control the secretion of neurotransmitters and hormones such as insulin.
This week at the annual Congress of Neurological Surgeons (CNS), Medtronic (NYSE: MDT) announced the Conformite Europeen (CE) mark and international launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions.
EnWave Corporation has received positive comments from the Patent Examiner with regard to the Company's Patent Co-Operation Treaty ("PCT") patent application for nutraREVTM equipment concept and use, leading the Company to believe that a favorable International Preliminary Report on Patentability ("IPRP") is forthcoming.
› Verified 5 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 27 |
| Hospitalization Rate in facility | 196.8 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 408.8 |
| Hospitalization Rate: Lower Confidence Limit | 100.4 |
News Archive
Deep brain stimulation, increasingly recognized as an effective therapy for certain cases of Parkinson's disease, dystonia and tremor, also may help patients who suffer from obsessive-compulsive disorder or depression that fails to respond to other treatments.
Researchers have capitalized on the unique properties of a sperm cell to follow cell membrane fusion as it occurs during fertilization, tracking the full cascade of events for the first time. The findings could reveal new ways to enhance or block fertilization, as well as how to control the secretion of neurotransmitters and hormones such as insulin.
This week at the annual Congress of Neurological Surgeons (CNS), Medtronic (NYSE: MDT) announced the Conformite Europeen (CE) mark and international launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions.
EnWave Corporation has received positive comments from the Patent Examiner with regard to the Company's Patent Co-Operation Treaty ("PCT") patent application for nutraREVTM equipment concept and use, leading the Company to believe that a favorable International Preliminary Report on Patentability ("IPRP") is forthcoming.
› Verified 5 days ago
The rate of readmission show you whether patients who were being treated regularly at Fmcna - Benton were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 30.1 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 43.8 |
| Readmission Rate: Lower Confidence Limit | 18.7 |
News Archive
Deep brain stimulation, increasingly recognized as an effective therapy for certain cases of Parkinson's disease, dystonia and tremor, also may help patients who suffer from obsessive-compulsive disorder or depression that fails to respond to other treatments.
Researchers have capitalized on the unique properties of a sperm cell to follow cell membrane fusion as it occurs during fertilization, tracking the full cascade of events for the first time. The findings could reveal new ways to enhance or block fertilization, as well as how to control the secretion of neurotransmitters and hormones such as insulin.
This week at the annual Congress of Neurological Surgeons (CNS), Medtronic (NYSE: MDT) announced the Conformite Europeen (CE) mark and international launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions.
EnWave Corporation has received positive comments from the Patent Examiner with regard to the Company's Patent Co-Operation Treaty ("PCT") patent application for nutraREVTM equipment concept and use, leading the Company to believe that a favorable International Preliminary Report on Patentability ("IPRP") is forthcoming.
› Verified 5 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Fmcna - Benton get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 3.06 (Worse than Expected) |
| SIR: Upper Confidence Limit | 6.37 |
| SIR: Lower Confidence Limit | 1.24 |
News Archive
Deep brain stimulation, increasingly recognized as an effective therapy for certain cases of Parkinson's disease, dystonia and tremor, also may help patients who suffer from obsessive-compulsive disorder or depression that fails to respond to other treatments.
Researchers have capitalized on the unique properties of a sperm cell to follow cell membrane fusion as it occurs during fertilization, tracking the full cascade of events for the first time. The findings could reveal new ways to enhance or block fertilization, as well as how to control the secretion of neurotransmitters and hormones such as insulin.
This week at the annual Congress of Neurological Surgeons (CNS), Medtronic (NYSE: MDT) announced the Conformite Europeen (CE) mark and international launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions.
EnWave Corporation has received positive comments from the Patent Examiner with regard to the Company's Patent Co-Operation Treaty ("PCT") patent application for nutraREVTM equipment concept and use, leading the Company to believe that a favorable International Preliminary Report on Patentability ("IPRP") is forthcoming.
› Verified 5 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Fmcna - Benton's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 24 |
| Transfusion Rate in facility | 21 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 161.6 |
| Transfusion Rate: Lower Confidence Limit | 3.5 |
News Archive
Deep brain stimulation, increasingly recognized as an effective therapy for certain cases of Parkinson's disease, dystonia and tremor, also may help patients who suffer from obsessive-compulsive disorder or depression that fails to respond to other treatments.
Researchers have capitalized on the unique properties of a sperm cell to follow cell membrane fusion as it occurs during fertilization, tracking the full cascade of events for the first time. The findings could reveal new ways to enhance or block fertilization, as well as how to control the secretion of neurotransmitters and hormones such as insulin.
This week at the annual Congress of Neurological Surgeons (CNS), Medtronic (NYSE: MDT) announced the Conformite Europeen (CE) mark and international launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions.
EnWave Corporation has received positive comments from the Patent Examiner with regard to the Company's Patent Co-Operation Treaty ("PCT") patent application for nutraREVTM equipment concept and use, leading the Company to believe that a favorable International Preliminary Report on Patentability ("IPRP") is forthcoming.
› Verified 5 days ago
The rate of mortality show you whether patients who were being treated regularly at Fmcna - Benton lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 162 |
| Mortality Rate in facility | 24.8 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 36.1 |
| Mortality Rate: Lower Confidence Limit | 16.3 |
News Archive
Deep brain stimulation, increasingly recognized as an effective therapy for certain cases of Parkinson's disease, dystonia and tremor, also may help patients who suffer from obsessive-compulsive disorder or depression that fails to respond to other treatments.
Researchers have capitalized on the unique properties of a sperm cell to follow cell membrane fusion as it occurs during fertilization, tracking the full cascade of events for the first time. The findings could reveal new ways to enhance or block fertilization, as well as how to control the secretion of neurotransmitters and hormones such as insulin.
This week at the annual Congress of Neurological Surgeons (CNS), Medtronic (NYSE: MDT) announced the Conformite Europeen (CE) mark and international launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions.
EnWave Corporation has received positive comments from the Patent Examiner with regard to the Company's Patent Co-Operation Treaty ("PCT") patent application for nutraREVTM equipment concept and use, leading the Company to believe that a favorable International Preliminary Report on Patentability ("IPRP") is forthcoming.
› Verified 5 days ago
Davita - Saline County Dialysis Location: Ground Level-1200 N Main Ste 2, Benton, Arkansas, 72015 Phone: (501) 776-1816 |
News Archive
Deep brain stimulation, increasingly recognized as an effective therapy for certain cases of Parkinson's disease, dystonia and tremor, also may help patients who suffer from obsessive-compulsive disorder or depression that fails to respond to other treatments.
Researchers have capitalized on the unique properties of a sperm cell to follow cell membrane fusion as it occurs during fertilization, tracking the full cascade of events for the first time. The findings could reveal new ways to enhance or block fertilization, as well as how to control the secretion of neurotransmitters and hormones such as insulin.
This week at the annual Congress of Neurological Surgeons (CNS), Medtronic (NYSE: MDT) announced the Conformite Europeen (CE) mark and international launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions.
EnWave Corporation has received positive comments from the Patent Examiner with regard to the Company's Patent Co-Operation Treaty ("PCT") patent application for nutraREVTM equipment concept and use, leading the Company to believe that a favorable International Preliminary Report on Patentability ("IPRP") is forthcoming.
› Verified 5 days ago